Gene · 1595
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STAT1 signaling controls cholesterol metabolism in epithelial cells and RSV-induced syncytia formation. | Npj Viruses | 2026 | 41699197 | PubTator, text mining | PubMed |
| A hybrid feature extraction framework combining PCA and mutual information for gene expression based lung cancer classification. | PLoS One | 2026 | 41642802 | PubTator, text mining | PubMed |
| A genome-wide association meta-analysis of cholesterol synthesis intermediates identifies three associations for lanosterol. | EBioMedicine | 2026 | 41619350 | PubTator, text mining | PubMed |
| Cytotoxic and Antileishmanial Potential of Pilocarpus microphyllus Essential Oil: In Vitro and In Silico Study. | Chem Biodivers | 2026 | 41532848 | PubTator, text mining | PubMed |
| Cholesterol and steroid synthesis pathways may be involved in the inhibition of osteosarcoma cell viability by calcium-sensing receptor antagonism. | PeerJ | 2026 | 41522513 | PubTator, text mining | PubMed |
| Sensitivity to demethylation-inhibiting fungicides and induced expression of CYP51 associated with tebuconazole resistance in Alternaria species on mandarin in Brazil. | Pest Manag Sci | 2026 | 41432017 | PubTator, text mining | PubMed |
| Efficacy of Itraconazole Pulse Therapy Versus Q-Switched Nd-YAG Laser Versus Combination of Both in the Treatment of Onychomycosis-A Single-Blind Randomized Control Trial. | J Cutan Med Surg | 2026 | 41243308 | PubTator, text mining | PubMed |
| Azole Antifungals Under Pressure: Therapeutic Challenges and Multifaceted Resistance Mechanisms. | Curr Med Chem | 2026 | 40908528 | PubTator, text mining | PubMed |
| Peroxidation rate constants and mechanisms of isoprenoid-derived lipids and their roles in ferroptosis. | Redox Biochem Chem | 2025 | 42273072 | PubTator, text mining | PubMed |
| [BMIM]OAc promoted one-pot synthesis of pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidin-5-ones and their antimicrobial activity. | RSC Adv | 2025 | 41488508 | PubTator, text mining | PubMed |
| A bypass gateway from cholesterol to sex steroid biosynthesis circumnavigates CYP17A1. | Nat Commun | 2025 | 41345099 | PubTator, text mining | PubMed |
| The quadro-iliac plane block: a systematic review of a promising novel technique. | BMC Surg | 2025 | 41286753 | PubTator, text mining | PubMed |
| Design, synthesis, and activity evaluation of novel tetrazole-based CYP51 inhibitors. | Bioorg Chem | 2025 | 41172779 | PubTator, text mining | PubMed |
| Synthesis, Spectroscopic Characterization, and Biological Evaluation of a Novel Acyclic Heterocyclic Compound: Anticancer, Antioxidant, Antifungal, and Molecular Docking Studies. | Pharmaceuticals (Basel) | 2025 | 41155648 | PubTator, text mining | PubMed |
| Co-Treatment with Ritonavir or Sertraline Enhances Itraconazole Efficacy Against Azole-Resistant Trichophyton indotineae Isolates. | J Fungi (Basel) | 2025 | 41149888 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of 2-phenylthiazole CYP51 inhibitors. | RSC Med Chem | 2025 | 41127250 | PubTator, text mining | PubMed |
| Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against Trichophyton and Microsporum with No Anti-Candida Effect. | Int J Mol Sci | 2025 | 41096704 | PubTator, text mining | PubMed |
| Design, synthesis, and antifungal activity of novel amide imidazole CYP51 inhibitors with aromatic fused ring hydrophobic side chains. | RSC Med Chem | 2025 | 41078575 | PubTator, text mining | PubMed |
| A comprehensive review of targeting sterol 14α-demethylase and sterol C-24 methyl transferase, two pivotal proteins in Leishmania, as compelling therapeutic targets. | Bioorg Chem | 2025 | 41027231 | PubTator, text mining | PubMed |
| A Comprehensive Overview of Candida albicans as the Leading Pathogen in Vulvovaginal Candidiasis. | J Fungi (Basel) | 2025 | 41003178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1595/papers?page=3